Navigation Links
Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinson's Disease
Date:10/8/2007

- Data Presented at the 132nd Annual Meeting of the American Neurological

Association in Washington, D.C. -

ATLANTA, Oct. 8 /PRNewswire/ -- UCB, Inc. presented data from two clinical trials that showed Neupro(R) (Rotigotine Transdermal System), a once-daily non-ergolinic dopamine agonist patch, is effective in controlling early morning motor impairment, provides improvement in sleep quality, and is generally well-tolerated for long-term use in patients with Parkinson's disease. Studies examining patients who have either early or advanced-stage Parkinson's disease were also presented.

"Neupro offers continuous delivery of a dopamine agonist for 24 hours, leading to stable plasma levels," said Rajesh Pahwa, M.D., Professor of Neurology and Director of the Parkinson Disease and Movement Disorder Center at the University of Kansas Medical Center. "These data showed that Neupro has a positive effect on patients' early morning symptoms, improves quality of sleep, and is generally well-tolerated for long-term use in patients with Parkinson's disease." Dr. Pahwa is an investigator for the long-term, open- label study.

An open-label, single-arm, exploratory 18-week study investigated the efficacy of Neupro(R) on early morning motor impairment and sleep disorders. Fifty-four patients with mostly advanced-stage Parkinson's disease and unsatisfactory control of these symptoms received Neupro(R) in doses from 4 to 16 mg/24 hours during a 4-week maintenance period. Motor improvement upon waking and changes in sleep disturbances were assessed.

Forty-nine percent of patients treated per protocol with Neupro(R) showed considerable improvement in early morning motor function sufficient to meet response criteria (greater than or equal to 30% improvement of UPDRS III score). Nocturnal akinesia -- inability to move at night -- was reduced by 56%, and improvement was also noted in nocturnal dystonia -- painful muscle contraction -- and
'/>"/>

SOURCE UCB, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
2. NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine
3. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
4. 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)
5. Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter
6. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
7. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
8. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
9. Gabapentin Shown Effective for Fibromyalgia Pain
10. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
11. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  In an unprecedented effort to curb the spread of "superbugs" ... transport vehicles, an advanced and portable UV germicidal lamp manufactured by ... time. In order to prevent EMS paramedics and ... West Palm Beach Fire Rescue is the first ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... developing its Symphony® CGM System as a non-invasive, wireless ... F. Doman , Executive Chairman and Interim CEO of ... Markets, Tenth Annual Equity Conference. Mr. ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Insulin ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
(Date:4/17/2014)... today in PLOS Pathogens , children who live ... can mount an immune response to infection with malaria ... of high fever and illness and partially control the ... may help researchers develop future interventions that prevent or ... Each year, approximately 200 million cases of malaria occur ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
(Date:4/17/2014)... 10 million older Americans suffer from depression, often brought ... new research a project that followed the lives ... found that Internet use among the elderly can ... percent. , "That,s a very strong effect," said Shelia ... studies and media who led the project. "And it ...
(Date:4/17/2014)... a new mechanism that allows blood to enter the ... and the Salk Institute have opened the door to ... damage. , A complex and devastating neurological condition, stroke ... for disability in the U.S. The blood-brain barrier is ... into the brain, causing the permanent deficits in movement ...
Breaking Medicine News(10 mins):Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... New GoodBelly Brings Together Delicious, Antioxidant-Rich Fruit and ... of the Hottest Food Trends for 2008, ... Foods,Industry pioneer Steve Demos is launching GoodBelly(TM) -- ... probiotics and,antioxidant-rich fruit ( http://www.goodbelly.com ). Probiotics -- ...
... food items aimed specifically at children have a poor nutritional ... sodium - according to a detailed study of 367 products ... Obesity Reviews . , Just under 70 per cent ... drinks and bakery items - derived a high proportion of ...
... Brings New technology for On-line tracking and Document Access, ... Board, LLC,announces the launch of an automated web based ... clients to,securely log onto a website 24 hours a ... their study. The system also allows,clients to access approval ...
... CRME TSX: COM, VANCOUVER, July 14 /PRNewswire-FirstCall/ ... today announced positive clinical results from,its 90-day Phase ... statistically significant efficacy for the patient group,receiving 500mg ... The,safety data from the final analysis also shows ...
... New Tools and Features Build Upon the Trusted Experience 100 ... Families Have Come to Know, Love and Depend ... Internet,s,largest resource for new and expectant parents around the world, ... network,enables members to share and connect with each other and ...
... - Platform,s Online Content Doubled in Less Than ... scientific, technical and medical,(STM) information, today announced that ... million full-text articles., Doubling its content in ... most extensive online STM research platform. Serving the,evolving ...
Cached Medicine News:Health News:Introducing GoodBelly(TM) the New Probiotic Fruit Drink Line 2Health News:89 percent of children's food products provide poor nutritional quality 2Health News:89 percent of children's food products provide poor nutritional quality 3Health News:89 percent of children's food products provide poor nutritional quality 4Health News:Aspire IRB Announces the Launch of an Automated Web Portal System 2Health News:Cardiome Announces Positive Phase 2b Results For Oral Vernakalant 2Health News:Cardiome Announces Positive Phase 2b Results For Oral Vernakalant 3Health News:Cardiome Announces Positive Phase 2b Results For Oral Vernakalant 4Health News:Cardiome Announces Positive Phase 2b Results For Oral Vernakalant 5Health News:BabyCenter Launches Social Network for Largest Parenting Community Online 2Health News:BabyCenter Launches Social Network for Largest Parenting Community Online 3Health News:Elsevier's "ScienceDirect" Articles Surpass Nine-Million Mark 2Health News:Elsevier's "ScienceDirect" Articles Surpass Nine-Million Mark 3
... Cage is a sport functional ... of combined ACL and PCL ... to the medial collateral ligament ... can be supported. The Hi-Impact ...
... best, the Bledsoe Extender Brace meets the physicians' ... to 86 cm) in length and up to ... easily fits patients from 5' (152 cm) to ... the patient progresses. The Bledsoe Extender is so ...
... The Bledsoe Lever Lock Knee ... quick extension lock of the arthroscopic ... to allow motion for rehabilitation or ... quickly locked "rigidly" in full extension ...
The Bledsoe Adjustable Knee Brace is designed to meet the most stringent demands of post-op care. When post-op care demands the best, the Bledsoe Adjustable Knee Brace is the physicians' preferred ch...
Medicine Products: